Lumion utevcklar ett bokföringsprogram som gör bokföring superenkel för småföretagare så att de kan bokföra och förstå sin ekonomi utan konsulthjälp. Små aktiebolag i Sverige brottas dagligen med bokföring och administration som upplevs som krånglig, tidskrävande och riskfylld. Existerande system är kraftfulla men i första hand byggda för redovisningskonsulter, inte för företagare själva. Resultatet blir att entreprenörer fastnar i komplexa gränssnitt, gör fel eller tvingas betala 15 000 - 50 000 kr per år till byråer för relativt enkla uppgifter. Detta skapar onödig stress, höga kostnader och en känsla av att inte ha kontroll över bolagets ekonomi. Lumion hjälper småföretagare att hantera och förstå sin ekonomi. Vi använder en kraftfull modell byggd på praxis, lagverk och standardisering för att ge användarna ett lättförståeligt språk, enkla vyer och rätt information. På så vis kan de få tryggheten och smidigheten de behöver, utan att betala dyra konsulter. Vår ambition är att förenkla administration så att vi kan hjälpa företagare förstå bolagets ekonomi bättre. Lumion ger mindre företag en användarvänlig upplevelse som hjälper dem förenkla hanteringen av sin ekonomi, vilket på sikt kan hjälpa dem att fatta bättre ekonomiska beslut. På så vis kan företagarna spendera mer tid på att utveckla verksamheten och mindre tid begravd i bokföring, administration och trassel.

DFRNT provides the world’s most reliable business information exchange through the platform for justified trust; including model-based business reporting infrastructure with the Twinfox product; and semantic data hub solutions through the DFRNT Studio product. The Twinfox and DFRNT Studio product suites enables business professionals to replace current manual error-prone information processing with spreadsheet software for financial planning and analysis, with effective and efficient processes where quality control is built into the information toolchain, enabling business professionals to achieve high quality results significantly faster, better and cheaper than today.

Coherra is building the leading digital media for finance. We are building virtual relationships by connecting the asset manager with key investors and sharing personalized content that matches their investor preferences. We are redesigning the distribution of financial information, and our global first approach makes it possible for the asset manager to reach a much greater audience and for the investor to locate the unique investor opportunity. Our engine is built using advanced machine learning and analytics of investor behaviour to develop a personalized algorithm tailored to meet the criteria of each investor.

At Birdie Studio, we’re building Birdie – a platform that finally fixes the biggest reason most AI tools fail in B2B marketing: bad input. AI can write fast, but if it doesn’t know your brand, your market, your goals, or your customers — it just makes things up. That’s a huge risk for marketing teams trying to move fast and stay on-message. Birdie changes that. We structure all of a company’s GTM knowledge — from strategy decks and sales insights to product positioning and audience research — and use it to power AI tools that create content that’s on-strategy, on-brand, and actually useful. We’re not building generic chatbots. We’re building the execution engine modern B2B teams need to go from idea to campaign — with AI that doesn’t guess, but understands.

Engrafo supplies a knowledge sharing platform which automatically and structured collects information about your business critical data and how they’re used for analysis and reports throughout your organization. And with the new AI LLM integration, Engrafo goes beyond cataloging. You can now select data from your catalog and have advanced AI models automatically generate: High-level dataflow descriptions — clear, non-technical summaries for business users. Program pseudocode — targeting different programming languages (Python, C#, Java, SQL, and more). Flowcharts & process diagrams — automatically visualizing program logic and data flows. High-level data usage descriptions — showing where, how, and why data is used. GDPR compliance overviews — quick snapshots of personal data handling and potential compliance considerations. And much more… — from data lineage narratives to impact analysis drafts. All our customers had the need for atomizing their data documentation. They also wanted to get rid of multiple Word and Excel templates and have one entrance for documenting their work with data. And also, they didn’t want the IT-departments to be bottlenecks. They believe in crowd enrichment and democratizing data and data knowledge

Based at Copenhagen Fintech, we are a small team that develop innovative solutions to cut the cost and complexity of european regulation, risk management, and make board reporting more efficient. Our solution is a SaaS platform where the user can manage regulations, risks, reporting and controls in a easy and intuitive way. Backed by the Danish Innovation Fund from April 2025 and piloting with scandinavian banks, asset managers and crypto service providers.

PharosBio is building an autonomous AI scientist—a platform and APIs that help biopharma and research teams reduce R&D risk by turning fragmented evidence into decisions across discovery and translation. The problem Despite billions spent on R&D, the research ecosystem runs on incomplete, siloed insight. Around 90% of drug candidates still fail in the clinic, wasting time and capital and delaying therapies for patients. This affects 4.5 million scientists across pharma, biotech, and academia who must constantly decide what to study, why it matters, and whether to proceed—with evidence that’s scattered and stale. Our solution We’re building the first agentic AI built for life sciences: a system that plans, reads, reasons, and writes like a tireless collaborator, and plugs into existing workflows via APIs. What it does • Target discovery & repurposing: surfaces novel targets and repositioning opportunities from literature and data; ranks by mechanism and evidence strength. • Translational go/no-go: aggregates preclinical and clinical signals to support milestone decisions with transparent rationales. • Scientific writing copilot: drafts systematic reviews, grant sections, IND-supporting summaries, and patent landscape briefs with citations. How it fits • Platform + APIs integrate with existing tools and pipelines. • Evidence-first UX: every recommendation is linked to sources; uncertainty is quantified. • Autonomy with control: agents run end-to-end tasks, while scientists supervise, edit, and approve. Outcomes • Faster time to insight, • Fewer dead-ends, • Higher confidence at each stage from early discovery to translation. Our motivation We’re expats who fell in love with Denmark’s research culture and collaborative ecosystem. We started PharosBio because agentic AI is powerful but under-applied where it matters most—healthcare, research, and biotech. Watching promising ideas stall for lack of clear evidence lit the spark: we want to equip every scientist with an always-on partner, so more therapies reach patients - us and our loved ones!

We are building the future of finance, with automated agents that can handle repetitive and crucial operations. And we are scaling fast. We currently handle 100s of thousands of consumer interactions across our customers, that have direct impact on their operations and the lives of their consumers. Turning difficult and gnarly problems, into a streamlined process.

At Tandem, we create tailor-made BI and digital solutions with intent. Built around [ you ]. Intended for [ use ]. We serve organizations that need to transform their data into strategic advantage. For teams seeking structured insights and practical tools that deliver measurable impact. For businesses requiring digital solutions that integrate seamlessly into existing operations. This is our focus. We bridge technology and business outcomes. Every solution is customized and crafted with the end-user in mind. We combine technical expertise with commercial insight and a methodical approach to each engagement. This means close collaboration and investing time to understand both the challenge and the stakeholders involved. Our BI solutions deliver genuine business value while remaining accessible to those who use them daily. We develop dashboards that translate complex data into clear insights and actionable intelligence. Our digital solutions follow the same principle: sophisticated technology made practical, complex challenges resolved efficiently. No unnecessary complexity, no technical barriers. Clear, actionable intelligence and digital tools that enhance decision-making and operational efficiency. We founded Tandem after observing too many organizations struggle to extract value from their technology investments. We had seen how the right insights, properly presented, could transform not just strategies but entire business models. How digital solutions, when correctly implemented and adopted, could accelerate growth rather than create friction. We recognized the need for a different approach—one that balanced technical sophistication with practical application. That conviction guides our work. We are not here to showcase complexity or deliver generic solutions. We are here to partner with organizations in extracting meaningful value from their data and technology, creating solutions that are as powerful as they are practical.

Advanced Precision Systems (APS) is a Norwegian defense-tech startup developing Fenix, a software module for aerial strike drones that enables in-motion release of low-cost, unguided munitions against ground targets. Unlike kamikaze systems, the aircraft returns for reuse, lowering per-strike cost and reducing dependence on strained supply chains.

Calibras digitalizes Manufacturing & Quality Control workflows. We actively develop and deploy MES systems, 3D and 2D measurement & process monitoring AI solutions, SPC automation and various multimodal Data Science & RAG pipelines, all integrated into the end customers factory and laboratory framework. Our development approach is based on merging our manufacturing domain knowledge with full-stack software expertise, delivering our clients with E2E solutions of highest quality. We go beyond AI generated insights, adding a level of manufacturing context, ISO standards compatibility, and integration with existing IoT, MLOps and Cloud systems, providing our clients with tailored products that show tangible value. We stand ready to be your trustworthy partner on your Industry 4.0 Digital Transformation journey.

Comeply is a pioneering SaaS compliance management platform designed specifically for organizations navigating the complex regulatory landscapes of highly regulated industries, with particular expertise in pharmaceutical compliance. We transform how companies understand, monitor, and maintain their compliance posture by delivering real-time regulatory intelligence coupled with powerful analytical capabilities. Our platform continuously scans, processes, and interprets regulatory changes from authoritative sources including ICH, FDA, EMA, eCFR, and pharmacopoeias, creating an always-current compliance knowledge base. What sets Comeply apart is our unique ability to automatically compare regulatory requirements against a company's internal quality management documentation, identifying compliance gaps and potential risk areas before they become issues. We provide dynamic compliance scoring that quantifies and visualizes compliance status across various regulatory domains such as safety, site oversight, and quality management, enabling leadership to make informed decisions based on clear compliance metrics. When regulations evolve, our sophisticated delta analysis highlights specific differences between previous and updated requirements, with targeted notifications that connect directly to the departments and processes affected within your organization. Beyond mere notification, Comeply delivers contextual understanding of regulatory changes, showing precisely how they impact your current compliance position and what actions may be required. By automating the labor-intensive processes of regulatory monitoring and interpretation, we enable compliance and quality assurance teams to shift from reactive document management to strategic compliance leadership, reducing compliance risk while simultaneously cutting monitoring costs by up to 80%. For pharmaceutical companies and other organizations where regulatory excellence is non-negotiable, Comeply transforms compliance from an operational burden into a sustainable competitive advantage.

Thyr is a modern travel platform helping curious and style-driven explorers plan, experience, and share unique journeys with ease. We offer inspiring travel stories, digital guides, and curated products – like Lightroom presets, ready-made itineraries, and online travel courses – designed to make travel feel more accessible and personal. Whether it's a weekend in the Norwegian fjords or a solo trip through Southeast Asia, Thyr.no helps users make the most of their time, budget, and adventure.

Swirl is the go-to wine discovery app for anyone who wants to find wines they truly enjoy. With truly personalised recommendations, expert tools, and an easy-to-use wine tracker, Swirl helps users build confidence in their wine choices. Whether you're browsing at a store or ordering at a restaurant, Swirl ensures every sip is the right one.

ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential. ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.